Category: Medicine

Image Credit: © iDoPixBox – stock.adobe.com Merck and Moderna have announced the initiation of a Phase III clinical trial evaluating…

Credit: Uladzislau | stock.adobe.com Patients with moderate to severe Crohn disease (CD) administered treatment with subcutaneous (SC) Tremfya (guselkumab) achieved…

Sustainability in clinical research is key. As complexity and productivity in the industry continue to rise, so does the need…

Credit: antkevyv | stock.adobe.com A pair of multiyear Phase III trials show that Eli Lilly’s Omvoh (mirikizumab) produced stable, long-term…

October 16th 2024 Podcast Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with…

Credit: santoelia | stock.adobe.com Headline data from the Phase III SOUL trial found that oral semaglutide (Rybelsus) lowered major adverse…

Christine Senn, Vice President, Site/Sponsor Innovation, Advarra Clinical research is more complicated and expensive than ever. That means the journey…

In a recent video interview with Applied Clinical Trials, Jimmy Bechtel, vice president, site engagement, SCRS, discussed key challenges and initiatives…

Conferences offer the clinical research industry a fantastic opportunity to meet face-to-face. Between friendly conversations and interactive sessions, key leaders…

Credit: ltyuan | stock.adobe.com Ebglyss (lebrikizumab-lbkz) was found to significantly improve skin symptoms and decrease itching in patients with moderate-to-severe atopic…

The shift towards technology and other decentralized approaches in clinical trials has been occurring for years now. The promise of…

Credit: Julia | stock.adobe.com A pair of clinical trials demonstrated that GSK’s respiratory syncytial virus (RSV) vaccine Arexvy produced a…

In recent years, the artificial intelligence (AI)-hype train has picked up steam. Its promise has caught the attention of countless…

In a recent video interview with Applied Clinical Trials, Silvio Galea, chief data & analytics officer, WCG, discussed the challenges in…

Pharmaceutical companies face numerous drug development challenges today, including low drug approval rates, rising drug discovery costs, pressure to accelerate…

Credit: Dr_Microbe | stock.adobe.com One year of treatment with Vabysmo (faricimab-svoa) for diabetic macular edema (DME) produced significantly improved vision among…

In June, the FDA released its Diversity Action Plan guidance. The document outlines requirements for sponsors on submitting diversity plans…

Credit: artegorov3@gmail | stock.adobe.com The novel combination of islatravir (Merck) and lenacapavir (Gilead) maintained high rates of viral suppression in…

Mike Hennessy Jr, president and CEO, MJH Life Sciences® Within the push for greater diversity of patient populations in clinical…

Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses: Current trends and challenges with achieving greater diversity in…

Image Credit: © Pixel-Shot – stock.adobe.com Clinical development in Parkinson’s disease (PD) faces numerous challenges and pitfalls. There is an…

Credit: Shuo | stock.adobe.com Artificial intelligence (AI) has had an undeniable impact on society in the past few years, having…

In a recent video interview with Applied Clinical Trials, Silvio Galea, chief data & analytics officer, WCG, discussed the challenges in…

Credit: kitsawet | stock.adobe.com The results of the Phase IIb/III MK-1654-004 trial (NCT04767373) show that clesrovimab (Merck) produced a significant…

In a recent video interview with Applied Clinical Trials, Silvio Galea, chief data & analytics officer, WCG, discussed the challenges in…

Credit: Dzmitry | stock.adobe.com The combination of Opdivo (nivolumab) plus chemotherapy was found to significantly improve progression-free survival (PFS) with…

ACT: You’ve been in the clinical research industry for more than 25 years. Can you please tell us a little…

Credit: jarun011 | stock.adobe.com Real-world data demonstrated that Apretude (cabotegravir long-acting [CAB-LA]; ViiV Healthcare) for HIV pre-exposure prophylaxis (PrEP) produced…

Steve Young, Chief Scientific Officer, CluePoints For more than a decade, the FDA and European Medicines Agency have encouraged the…

Elisa Mansfield, Vice President, FSP, Phastar The drug development landscape is continuously evolving. This evolution is ushering in a new…

Gerri Gallagher, Head, US Site Engagement, GSK Adam Kinsey, Associate VP, Clinical Operations and Regional Head, North America, Merck Mark…

Brian S. McGowan, PhD, FACEHP, Chief Learning Officer and Co-Founder, ArcheMedX, Inc. In clinical research, the stakes are high, and…

In a recent video interview with Applied Clinical Trials, Mwango Kashoki, SVP, global head of regulatory strategy, Parexel, discussed the…

Discover how to handle participant payments in global studies with ease. Join us to learn practical tips and new strategies…

Join experts from IQVIA Biotech and IQVIA in a webinar focused on enhancing clinical trial conduct by prioritizing patient-centric approaches.…

Credit: luchschenF | stock.adobe.com Pooled data from the Phase III GALAXI trial (NCT03466411) and the Phase III QUASAR maintenance trial…

To date, there is limited insight into the perspectives on eConsent in clinical trials of Independent Ethics Committees/Institutional Review Boards,…

In a recent video interview with Applied Clinical Trials, Mwango Kashoki, SVP, global head of regulatory strategy, Parexel, discussed the…

Image Credit: © Aerial Mike – stock.adobe.com GSK has shared positive Phase III data from its AReSVi-006 trial of Arexvy,…

The holy trinity of trial optimization At the core of trial optimization lies what the authors call the “holy trinity”…

In a recent video interview with Applied Clinical Trials, Mwango Kashoki, SVP, global head of regulatory strategy, Parexel, discussed the…

Credit: Lars Neumann | stock.adobe.com Keytruda (pembrolizumab) produced a significant improvement in event-free survival (EFS) and major pathological response as a…

Image Credit: © Egor – stock.adobe.com We’re witnessing significant changes in how trial sites interact with biopharmaceutical organizations.The adoption of…

In a recent video interview with Applied Clinical Trials, Erin Erginer, director of product, Certara discussed the growing complexity and…

Image Credit: © Production Perig – stock.adobe.com Emergex Vaccines has announced that the National Institute of Allergy and Infectious Diseases…

Credit: kitsawet | stock.adobe.com Ziresovir produced significantly greater clinical improvement, decreased viral load, and reduced the Wang bronchiolitis clinical score…

• A one-size-fits-all model no longer exists. Because of this, Parexel’s models are flexible and agile, designed to adapt to…

Liz Rogers, VP and Head of Global Site and Study Operations at Pfizer, discusses Pfizer’s partnership with Parexel and transition…

Credit: luchschenF | stock.adobe.com Findings from the Phase II PATH-HHT trial (NCT03910244) show that pomalidomide significantly lowered the Epistaxis Severity…

Tony Southers, Executive Vice President, Head of ICON Strategic Solutions In the new age of sourcing, sponsors are looking beyond the…

In a recent video interview with Applied Clinical Trials, Erin Erginer, director of product, Certara discussed the growing complexity and…

Image Credit: © Crystal light – stock.adobe.com Arcus Biosciences has announced a clinical trial collaboration agreement with AstraZeneca to evaluate…

In a recent video interview with Applied Clinical Trials, Erin Erginer, director of product, Certara discussed the growing complexity and…

Image Credit: © Andrii Yalanskyi – stock.adobe.com Results from a survey conducted by two Baltimore medical centers suggest spiritual beliefs…

In a recent video interview with Applied Clinical Trials, Erin Erginer, director of product, Certara discussed the growing complexity and…

Image Credit: © ipopba – stock.adobe.com The pharmaceutical industry is facing a challenging landscape where the cost of bringing new…

ACT: Looking forward, how will real-world evidence (RWE) drive point-of-care decisions? Gliklich: I love this question because one of the…

Image Credit: © FlowStudio – stock.adobe.com Cancer incidence in the United States is on the rise. According to the American…

ACT: Is there any potential for the use of artificial intelligence (AI) in the data collection space? Gliklich: I love…

Credit: Saiful52 | stock.adobe.com Bristol Myers Squibb (BMS) and 2seventy bio announced the discontinuation of enrollment in the Phase III…

ACT: How can the integration of real-world data (RWD) reduce burden for key stakeholders in a trial such as sites,…

This webinar, hosted by Avacare Clinical Research Network, will provide a comprehensive understanding of why clinical trial diversity matters and…

ACT: What are some key regulatory requirements or challenges that need to be addressed when using real-world data (RWD)? Gliklich:…

Credit: GoodIdeas | stock.adobe.com Findings from the Phase III REGENCY trial (NCT04221477) demonstrated that Gazyva/Gazyvaro (obinutuzumab; Roche) in combination with…

Image Credit: © NicoElNino – stock.adobe.com As the field of clinical research undergoes rapid evolution, so too must the methodologies…

Image Credit: © Blue Planet Studio – stock.adobe.com Medidata has announced the launch of its newest solution, Patient Payments. Headlined…

Results from the ADjoin long-term extension study (NCT04392154) show that more than 80% of patients with moderate-to-severe atopic dermatitis (AD)…

Image Credit: © Jakub Krechowicz – stock.adobe.com While cancer affects all demographics, there is a noticeable difference in burden within…

Image Credit: © Christoph Burgstedt – stock.adobe.com IDEAYA Biosciences has shared positive interim Phase II data for darovasertib in neoadjuvant…

ACT: How important is the role of real-world data (RWD) in clinical research for cancer and other rare diseases? Gliklich:…

Credit: gpointstudio | stock.adobe.com Results from the Phase II AGAVE-201 trial (NCT04710576) show that (Niktimvo) axatilimab monotherapy is effective and…

ACT: You have an upcoming session on “Transforming Clinical Trials: From Reactive to Predictive.” What are some of the main…

ACT: Is there any potential for the use of AI when it comes to decision-making and enrollment? Lwoff: In the…

DPHARM’s “Aligning Innovations to Solve the Big Problems in Clinical Trials in a Resource-Constrained Environment” session When it comes to…

DPHARM’s “How Pharma is Shifting Operating Models for More Efficient Clinical Trials” session Sometimes, the innovation in things is to…

Image credit: freshidea | stock.adobe.com Findings from the Phase III NIAGARA trial (NCT03732677) show that Imfinzi (durvalumab) in combination with…

Image credit: THITIPORN | stock.adobe.com Results from the Phase III CABINET trial (NCT03375320) demonstrated that cabozantinib (Cabometyx, Cometriq) produced a…

Matt Cooper, PhD is an Executive Director and Therapeutic Strategy Lead, Oncology, at Worldwide Clinical Trials Jim Eamma is an…

ACT: You hosted a session on how to “Unlock the Power of the Patient for Better Patient Recruitment Outcomes.” What…

DPHARM’s “How Do You Make Scaling eSource EHR a Reality?” session Along its “New Approaches to Scale eSource EHR and…

ACT: What are some key considerations sponsors should be mindful of when aligning their decision-making process with the timeline of…

ACT: You have an upcoming session on “Harnessing AI/ML to Drive Sustained Community Engagement for Diverse Clinical Trial Participation.” What…

DPHARM’s “Unlock the Power of the Patient for Better Patient Recruitment Outcomes” session The first day of DPHARM in Philadelphia…

DPHARM’s “Examining Short and Long-Term ROI of DCT Deployment” session One of the first presentations to kick off DPHARM 2024…

Image Credit: Adobe Stock Images/penyushkin Data from Pfizer’s Phase II study of ponsegromab found that the treatment significantly improved body…

ACT: How important is it for CROs to form strong relationships with sites, especially in the rare disease space? Lwoff:…

Gabriel Bohl, PharmD, FTOPRA, Director, Regulatory Affairs, ICON plc In the rapidly evolving field of biologics, strategic chemistry, manufacturing, and…

Image credit: Tierney | stock.adobe.com Human-centered artificial intelligence (AI), which emphasizes harmoniously integrating technology and predictive analyses with a human…

Image credit: Dr_Microbe | stock.adobe.com Results from the first planned interim analysis of the Phase III ADRIATIC trial (NCT03703297) show…

Mike Hennessy Jr, president and CEO, MJH Life Sciences® Throughout 2024, we have witnessed a multitude of advancements in the…

Applied Clinical Trials September 2024 Issue (PDF) Aligning Technology and Oversight A New Regulatory Road in Clinical Trials: Digital Twins…

ACT: As the deadline for legal transition for EU clinical trials approaches, what strategies can companies deploy to smoothly navigate…

Gen Li, PhD, MBA, CEO and Founder, Phesi In recent decades, the complexity of clinical development has grown considerably. One…

ACT: What are the most impactful changes that companies need to be aware of? Neuberger: It was a different regulatory…

ACT: What does the EU’s clinical trial regulation aim to achieve? Neuberger: That is an important part. Why are we…

Craig Popovich, Associate Director, Implementation CIPP/E, Greenphire Solving site and sponsor clinical trial pain points with technology is hardly a…

Dee DeOliviera, senior director, global regulatory operations, Cerevel (now part of AbbVie) The evolving regulatory landscape in clinical research was…

Image Credit: © Supapeach – stock.adobe.com The FDA’s latest guidance on how trial sponsors should use real-world evidence (RWE) in…

Gadi Saarony, CEO, Advarra Stripped down to its fundamentals, drug development requires diverse participant representation for safe and effective treatments.…

ACT: To get started, could you give us an overview of your focus area at Veeva? Burks: I have the…

Attend this new, interactive webinar and join experts who reveal how sponsors can leverage technology to drive study efficiency. Learn…

Katsuyoshi Sugita, chief people officer and chief ethics & compliance officer at Astellas Pharma. Katsuyoshi Sugita, the chief people officer…

Image credit: magicmine | stock.adobe.com Trial results show that edoxaban monotherapy reduced the risk of the primary net clinical outcome…

Image credit: Damir Khabirov | stock.adobe.com A single intravenous (IV) infusion of Lundbeck’s investigational agent Lu AG09222 achieved superiority over…

Image credit: Rasi | stock.adobe.com Real world data demonstrated the efficacy of PCSK9 inhibitors in reducing low-density lipoprotein (LDL-C) cholesterol…

Image Credit: © Minerva Studio – stock.adobe.com Eli Lilly has shared positive study data from its QWINT clinical trial program…

Image Credit: © NicoElNino – stock.adobe.com Veeva Systems has announced the newest release of Veeva Site Connect. New capabilities of…

Image Credit: Adobe Stock Images/Generative AI In the past few years, there has been more of a focus on equity,…

Image Credit: © nespix – stock.adobe.com Medidata and Aixial Group have announced a new partnership to streamline clinical trial execution…

Norman M. Goldfarb, executive director of the Site Council and executive director of the Clinical Research Interoperability Standards Initiative (CRISI)…

Image credit: alexlmx | stock.adobe.com Data from the Phase III PALISADE trial (NCT05089084) demonstrated that plozasiran (Arrowhead) significantly reduced triglyceride…

Image Credit: © fotovapl – stock.adobe.com Valneva and Pfizer have shared positive Phase II results from their study of VLA15,…

ACT: Is there any potential for the use of artificial intelligence (AI) in budgeting and forecasting? If so, how? Murphy:…

July 30th 2024 Article Do you leverage a quality-first mindset as you evaluate clinical trial technology? When you evaluate eCOA…

Image Credit: Adobe Stock Images/Lila Patel Johnson & Johnson has announced the submission of a Biologics License Application (BLA) to…

Image credit: Molnia | stock.adobe.com Data is more important than ever in today’s challenging R&D environment, but as most lab…

ACT: What are some trends that you’re currently seeing with patient reimbursement? I mentioned the cost of travel reimbursement, those things…

Zach Bader (Vice President, Business Development) talked with ACT about how Dr. Vince Clinical Research (DVCR) is challenging the status…

Korey Nevitt (Executive Director, Site Partnerships) talked with ACT about what makes Dr. Vince Clinical Research (DVCR) solutions for clinical…

Image Credit: Adobe Stock Images/Best Results from a recent Phase II clinical trial conducted by Johns Hopkins Kimmel Cancer Center…

Image credit: growth.co | stock.adobe.com Findings from the Phase III CAHtalyst Pediatric Study (NCT04806451) show that crinecerfont (Neurocrine Biosciences) is…

Image Credit: © Rasi – stock.adobe.com Novartis has shared positive results from its Phase III study of Leqvio (inclisiran) in…

Image Credit: © Pixel-Shot – stock.adobe.com Palatin has announced receipt of FDA’s acceptance of protocols and endpoints for signs and…

ACT: What impact does patient data access have on elements such as forecasting, budgeting, and enrollment? Murphy: Well, there are…

Image Credit: © Crystal light – stock.adobe.com Astellas has announced the dosing of the first patient in its HIGHLIGHT 1…

ACT: What are some challenges that stakeholders are currently seeing with budgeting and analytics in their trials? Murphy: Well, the…

Image Credit: © Production Perig – stock.adobe.com The FDA has approved and granted emergency use authorization (EUA) for Pfizer and…

Image Credit: © AntonioDiaz – stock.adobe.com While the height of the COVID-19 pandemic is well behind us, its effects have…

Image credit: Minerva Studio | stock.adobe.com Weekly tirzepatide (Zepbound and Mounjaro; Eli Lilly) injections (5 mg, 10 mg, 15 mg) lowered…

Image credit: Laflor/peopleimages.com | stock.adobe.com Findings from a post-hoc analysis of the pivotal Phase III REST-ON trial (NCT02720744) show that patients with…

Image credit: MdBabul | stock.adobe.com Welireg (belzutifan) produced a significant benefit compared to everolimus (Afintior; Afinitor Disperz; Zortress) in progression-free survival…

ACT: What areas of trial design should stakeholders be focusing on the most to increase diversity within their studies? Moultrie:…

Image credit: Crystal light | stock.adobe.com Findings from a Phase III trial (NCT03709264) show that intravenous (IV) infusion of amino…

Image Credit: © Dr_Microbe – stock.adobe.com The FDA has cleared an Investigational New Drug (IND) application for an open-label, multicenter,…

ACT: What are your thoughts on the FDA’s recently released Diversity Action Plan Guidance? How will this affect sponsors moving…

Image Credit: © ArtyKris99 – stock.adobe.com Full data for the duo of Phase III studies—OASIS 1 and 2—has been published…

Image Credit: © Andrii Yalanskyi – stock.adobe.com Researchers at Tufts CSDD at the Tufts University School of Medicine, in collaboration…

ACT: What do you think are currently industry’s greatest obstacles in achieving more diversity in trials? Moultrie: I would say,…

Image Credit: © peshkova – stock.adobe.com Walgreens and the Biomedical Advanced Research and Development Authority (BARDA) have announced a strategic…

Image Credit: © iDoPixBox – stock.adobe.com The FDA has approved Johnson & Johnson’s Rybrevant (amivantamab-vmjw) plus Lazcluze (lazertinib) for the…

Applied Clinical Trials July/August 2024 Issue (PDF) Streamlining Clinical Trials with eSource: Insights from MSK Decentralized Clinical Trials: Bust or…

Image credit: Dr_Microbe | stock.adobe.com A retrospective, multicenter cohort study found that Xtandi (enzalutamide) achieved small but statistically significant improvements…

Image Credit: Adobe Stock Images/appledesign Results from the Acclaim study program found that Genprex’s Reqorsa (quaratusugene ozeplasmid) demonstrated promise in…

What should be top of mind for stakeholders when they are deciding what clinical technology is best for their individual…

Tracking efforts to advance the mission and concept of “clinical research as a care option.”

ACT: How are the regulators viewing this current “boom” in clinical technology? How has their stance on it changed over…

Image Credit: Adobe Stock Images/arti om Pfizer and BioNTech announced that their mRNA-based combination vaccine program aimed at combating both…

Image Credit: © Aerial Mike – stock.adobe.com Incyte has shared positive Phase III results of its CD19-targeting monoclonal antibody, Monjuvi…

Image Credit: Adobe Stock Images/pakbung The FDA has granted Breakthrough Therapy Designation and Priority Review to AstraZeneca’s Infimzi (durvalumab), indicated…

Decentralized clinical trials (DCTs) are shapeshifting. Originally piloted 15 years ago and more recently catalyzed by the COVID-19 pandemic, DCTs…

Joachim Lövin, Workstream Lead on Modernizing Clinical Trial Conduct, TransCelerate BioPharma Inc., and DCT Specialist, Novo Nordisk In the following…

ACT: What are some challenges you are currently seeing with the integration of clinical technology? Easy: That is a huge…

Benjamin Marcum, MD, family practitioner, Stephenville Medical and Surgical Clinic, Privia Health Emerging investigators play a vital role in bringing…

Image Credit: Adobe Stock Images/Mahmud Pfizer announced top-line results from the ongoing Phase III MONeT (RSV IMmunizatiON Study for AdulTs…

Image Credit: Adobe Stock Images/Media Srock Results from a Phase III clinical trial demonstrated that Aldeyra Therapeutics’ Reproxalap demonstrated a…

Image Credit: © photon_photo – stock.adobe.com To date, eConsent adoption and tangible study data about eConsent outcomes are limited. The…

ACT: What do technology vendors need to focus on most when creating patient-centric solutions? Keunen: It seems obvious, but ask…

Jon Ernst talked with ACT about how PCM Trials are harmonizing various elements in the decentralized clinical trial process. Learn…

ACT: As a patient yourself, what specific features or functions do you look for in technology? Keunen: I went through…

Vito Romita, PhD, MSc, Senior Director, Global Project Management, Hematology/Oncology Therapeutic Unit, PPD clinical research business, Thermo Fisher Scientific Introduction…

Image credit: Saiful52 | stock.adobe.com The results of a Phase III trial show that the combination of Sarclisa (isatuximab-irfc; Sanofi)…

Image credit: adimas | stock.adobe.com Results from the Phase II UNITY trial demonstrated that nipocalimab delayed or stopped the development…

Image Credit: © iDoPixBox – stock.adobe.com Merck has announced the discontinuation of the Phase III KeyVibe-008 trial evaluating a fixed-dose…

Image Credit: © Egor – stock.adobe.com Concentric Analgesics has shared positive Phase II data for its leading postsurgical pain management…

Image credit: 9nong | stock.adobe.com A Phase III trial found that adding olanzapine to moderately emetogenic chemotherapy (MEC) regimens consisting…

Image credit: fusssergei | stock.adobe.com Findings from the Phase IIIb GUIDE clinical trial (NCT03818035) show that after early and complete…

Image Credit: © Africa Studio – stock.adobe.com Bayer has shared new data from the Phase III FINEARTS-HF clinical trial, showing…

Image Credit: © ckybe – stock.adobe.com According to new data revealed by Eli Lilly, tirzepatide significantly improved heart failure symptoms…

Image credit: Sebastian Kaulitzki | stock.adobe.com New clinical data published by JAMA Network Open indicates that immune checkpoint inhibitor (ICI)…

Image credit: Peter Hansen | stock.adobe.com Findings from a double-blind study (NCT05236517) show that once-daily oral semaglutide at a dose…

ACT: Specifically, how can these large language models (LLMs) improve trial design, recruitment, and analysis? Kondru: I want us to…

Join experts to explore regulatory strategies, clinical challenges, and operational models that speed up trials and bring patient treatments. Register…

ACT: Are there any opportunities for these AI models to leverage data such as real-world data (RWD)? If so, how?…

Norman M. Goldfarb, executive director of the Site Council and executive director of the Clinical Research Interoperability Standards Initiative (CRISI)…

Image credit: grinny | stock.adobe.com Antihypertensive medications may improve target organ damage (TOD) in patients with masked hypertension compared to…

Image credit: LASZLO | stock.adobe.com The combination of Blenrep (belantamab mafodotin), bortezomib, and dexamethasone (BVd) demonstrated a significant benefit in…

Image Credit: © PIC4U – stock.adobe.com Evorpacept, a CD47 blocker, has returned positive data from the Phase II ASPEN-06 clinical…

Image Credit: © Aerial Mike – stock.adobe.com PepGen has shared positive data from the CONNECT1-EDO51 Phase II trial (NCT06079736) of…

ACT: What is the current state of the use of large language models (LLMs) in clinical trials? Kondru: I think…

Image Credit: © chayantorn – stock.adobe.com AstraZeneca has shared positive, interim results from the AMPLIFY Phase III trial (NCT03836261) evaluating…

Vincent Keunen, founder and CEO of Andaman7 shares his thoughts on how industry can achieve true patient centricity through emerging…

Image Credit: © photon_photo – stock.adobe.com NewAmsterdam Pharma has shared positive results from its pivotal Phase III BROOKLYN clinical trial…

Image Credit: © LIGHTFIELD STUDIOS – stock.adobe.com Lomecel-B, a living cell product for the treatment of Alzheimer’s Disease, has met…

Image Credit: © Ezume Images – stock.adobe.com ViiV Healthcare has shared initial results from the 48-week Phase IV PASO DOBLE…

ACT: When it comes to clinical trials specifically, what do you think some of the most relevant themes were at…

ACT: What are your goals or objectives for DIA for the remainder of the year? Pierce: There are so many…

ACT: What kind of impact do you hope DIA and its conferences have within the clinical trials industry? Pierce: DIA…

Image credit: drimafilm | stock.adobe.com An early-phase clinical trial (NCT04264975) suggests that patients with cancer who have shown prior resistance…

Jim Wahl, vice president, client services, TruLab In the clinical trial ecosystem these days, patient-centricity has become quite the buzzword.…

Image Credit: © Design Cells – stock.adobe.com Giroctocogene fitelparvovec, an investigational gene therapy for the treatment of adults with moderately…

Image credit: MdBabul | stock.adobe.com Blincyto (blinatumomab; Amgen) added to consolidation chemotherapy produced a significant improvement in overall survival (OS)…

Image Credit: © Gary – stock.adobe.com Clesrovimab (MK-1654), Merck’s investigational prophylactic monoclonal antibody designed to protect infants from respiratory syncytial…

Image credit: Sebastian Kaulitzki | stock.adobe.com An analysis of two randomized clinical trials (NCT03398148 and NCT03398135) found that Skyrizi (risankizumab;…

ACT: What were your impressions of the sessions at DIA? Pierce: The sessions that I saw that were the most well…

Image credit: Crystal light | stock.adobe.com Felzartamab demonstrated a potential therapeutic benefit and an acceptable safety and adverse event (AE)…

ACT: What were your greatest takeaways from this year’s DIA Global Annual Meeting in San Diego? Pierce: This was my…

Image credit: sinhyu | stock.adobe.com A nested case-control study found that limiting the treatment duration of oral corticosteroids in patients…

Image Credit: © Andrii Yalanskyi – stock.adobe.com The newly released 2024 ISG Provider Lens global Life Sciences Digital Services report…

A large percentage of clinical trials are unable to stay on track. Jason Gagner talked with ACT about how PurpleLab…